For the year ending 2025-12-31, FBLG has $9,619K in assets. $3,463K in debts. $4,894K in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 4,894 | |||
| Prepaid expenses | 1,455 | |||
| Other current assets | 0 | |||
| Total current assets | 6,349 | |||
| Total property and equipment at cost | 1,290 | |||
| Less accumulated depreciation | 448 | |||
| Property and equipment, net | 842 | |||
| Operating lease right-of-use asset, net | 2,380 | |||
| Other assets | 48 | |||
| Total assets | 9,619 | |||
| Accounts payable and accrued expenses | 945 | |||
| Operating lease liability, short-term | 706 | |||
| Sepa put option liability | 108 | |||
| Short-term convertible debt | 0 | |||
| Total current liabilities | 1,759 | |||
| Operating lease liability, long-term | 1,704 | |||
| Total liabilities | 3,463 | |||
| Preferred stock, value | 0 | |||
| Preferred stock, value-Series CPreferred Stock | 0 | |||
| Voting common stock, 0.00001 par value 300,000,000 shares and 100,000,000 shares authorized as of december 31, 2025 and 2024, respectively 66,519,722 shares and 35,085,718 shares issued and outstanding as of december 31, 2025 and 2024, respectively | 1 | |||
| Additional paid-in capital | 60,319 | |||
| Accumulated deficit | -54,164 | |||
| Total stockholders equity | 6,156 | |||
| Total liabilities and stockholders equity | 9,619 | |||
FibroBiologics, Inc. (FBLG)
FibroBiologics, Inc. (FBLG)